Using Quantum Probe for Skin Tightening in Liposculpture Patients
Effects of QUANTUM Probe for Skin Rejuvenation and Subdermal Retraction in Patients Undergoing High-Definition Liposculpture
This study is testing if a new device called the Quantum probe can help tighten loose skin for adults getting liposculpture.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 80 (estimated) |
| Ages | 18 Years to 60 Years |
| Sex | All |
| Sponsor | Total Definer Research Group Academic / other |
| Locations | 1 site (Bogotá, DC) |
| Trial ID | NCT06958978 on ClinicalTrials.gov |
What this trial studies
This prospective study evaluates the safety and effectiveness of the Quantum probe, a bipolar radiofrequency device, in reducing skin laxity for patients undergoing High-Definition Liposculpture. The study aims to determine if the Quantum probe can enhance skin firmness and elasticity while assessing the influence of demographic factors on its effectiveness. Participants will be closely monitored before and after the procedure, with data collected on various clinical and surgical variables, as well as patient satisfaction. The study employs a non-randomized, non-controlled design, focusing on adult patients with measurable skin laxity.
Who should consider this trial
Good fit: Ideal candidates are healthy adults aged 18-60 undergoing High-Definition Liposculpture with measurable skin laxity.
Not a fit: Patients with significant comorbidities, autoimmune diseases, or those who are pregnant or breastfeeding will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could provide patients with improved skin tightness and a more youthful appearance following body contouring procedures.
How similar studies have performed: While the use of radiofrequency devices in aesthetic procedures is established, the specific application of the Quantum probe in this context is novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients undergoing body contouring procedures (liposuction or liposculpture), either individually or combined with a maximum of two other major aesthetic procedures involving face, breast, or dermolipectomy. * Healthy patients without underlying comorbidities (classified as ASA≤II) Exclusion Criteria: * Pregnant patients, patients planning to get pregnant, or in breastfeeding stage * Past medical history of any collagen disease or autoimmune conditions, including lupus, scleroderma, connective tissue disorders, rheumatoid arthritis, or multiple sclerosis. * Past medical history of skin disease including active skin infections, dermatitis, or history of keloid formation. * Patient with any metal implants or pacemakers * BMI ≥ 32 kg/m2.
Where this trial is running
Bogotá, DC
- Dhara clinic — Bogotá, Dc, Colombia (Recruiting)
Study contacts
- Study coordinator: Alfredo Hoyos, Plastic Surgeon
- Email: alhoyos@gmail.com
- Phone: +13059154274
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.